Elizabeth Ruzzo
Elizabeth Ruzzo is the Founder and CEO of adyn, where she applies her expertise in medical genetics, neuroscience, bioinformatics, and machine learning to advance precision medicine and women's health. She is also a member of Women Business Leaders of the US Health Care Industry Foundation. Previously, she was a Postdoctoral Research Scholar at UCLA.
adyn CEO Elizabeth Ruzzo launches genetic-and-hormone test this fall to predict birth-control side effects
Elizabeth Ruzzo, founder and CEO of Seattle startup adyn, is launching a fall test that analyzes genetic and hormone data to predict birth-control side effects and reduce trial-and-error prescribing. She aims to make scientific discovery more inclusive by addressing biases in medical research and offering users the option to opt into anonymous research.
adyn raises $2.5M seed round from Lux Capital, M13 and investors including 23andMe CEO to launch birth-control test
Seattle startup adyn raised a $2.5 million seed round co-led by Lux Capital and M13 to launch an at-home birth control optimization test later this year, and currently has a waitlist for early access. The test analyzes hormone levels to identify birth-control–related side effects and pairs personalized results with telemedicine and prescription delivery.
Organizations
See all 6-
adyn Founder, CEO 2020–present · current
-
WBL (Women Business Leaders of the US Health Care Industry Foundation) Member 2025–present · current
-
UCLA Postdoctoral Research Scholar 2014–2020 · past
Education
-
Y Combinator 2020
-
Duke University Doctor of Philosophy (Ph.D.), Genome Sciences/Genomics · 2008–2014
-
University of Washington Bachelor of Science (B.S.), Cell & Molecular Biology | Minors: Chemistry, Anthropology · 2005